Migdal Insurance & Financial Holdings’s KraneShares MSCI All China Health Care Index ETF KURE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-150
Closed -$3K 550
2022
Q3
$3K Hold
150
﹤0.01% 491
2022
Q2
$4K Hold
150
﹤0.01% 584
2022
Q1
$3K Sell
150
-450
-75% -$11K ﹤0.01% 587
2021
Q4
$17K Hold
600
﹤0.01% 568
2021
Q3
$22K Sell
600
-42,602
-99% -$1.66M ﹤0.01% 537
2021
Q2
$1.97M Buy
43,202
+2,707
+7% +$115K 0.02% 188
2021
Q1
$1.58M Buy
40,495
+14,302
+55% +$585K 0.02% 210
2020
Q4
$1.02M Buy
+26,193
New +$926K 0.01% 193

Other funds holding KURE

Migdal Insurance & Financial Holdings's KURE Position: Q4 2022 in Review

Migdal Insurance & Financial Holdings sold out of KraneShares MSCI All China Health Care Index ETF (KURE) in Q4 2022, closing a stake of 150 shares — an estimated $3K sold.

Migdal Insurance & Financial Holdings first reported a position in KURE in Q4 2020 and held it in 8 quarters. The position peaked at $1.97M in Q2 2021. 15 funds tracked by Wall St. Rank hold KURE as of Q4 2022.

  • Migdal Insurance & Financial Holdings reported no remaining KraneShares MSCI All China Health Care Index ETF position as of Q4 2022 after selling out during the quarter.
  • Migdal Insurance & Financial Holdings sold 150 KraneShares MSCI All China Health Care Index ETF shares in Q4 2022, an estimated $3K.
  • Migdal Insurance & Financial Holdings first reported a position in KraneShares MSCI All China Health Care Index ETF in Q4 2020 and held it in 8 quarters.
  • Migdal Insurance & Financial Holdings's KraneShares MSCI All China Health Care Index ETF position peaked at $1.97M in Q2 2021.
  • 15 funds tracked by Wall St. Rank held KraneShares MSCI All China Health Care Index ETF as of Q4 2022.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q4 2022, filed 23 Jan 2023.